October 7, 2013 | Israeli company Brainsway, which develops non-invasive treatments using transcranial magnetic stimulation (TMS), has raised NIS 24 million (approx. $6.8 million) on the Tel Aviv Stock Exchange (TASE). The company received an additional $1 million from a Japanese distributer over the weekend.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments